About Sasmar Pharmaceuticals Private Limited
Data last updated:
Sasmar Pharmaceuticals Private Limited is a foreign private limited company based in Perungudi, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2019FTC130734. Its GSTIN is 27ABCCS4161N1ZZ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Andrew Jon Soutter and John Michael Mancini.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Perungudi, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.93 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹42,229 (net margin -5.3%) and EBITDA of -₹42,229 (EBITDA margin -5.3%). Revenue has grown at a compounded annual rate (CAGR) of 70% over three years.
For more details, the company can be reached via its website sasmar.com.
Company details
Contact details
Sasmar Pharmaceuticals Private Limited's registered office is in Perungudi, Tamil Nadu. Its website is sasmar.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressDisruptors Of Tomorrow Coworking No. 87 4th Cross Street 1st Main Road Thirumal, Ai Nagar, Perungudi, Tamil Nadu, India – 600096
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sasmar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sasmar Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sasmar Pharmaceuticals Private Limited, buy the company report.
Financials of Sasmar Pharmaceuticals Private Limited
FY 2025 filings availableSasmar Pharmaceuticals Private Limited reported revenue of ₹7.93 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 70%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹42,229 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹42,229 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.3% | ||||
| Net Profit Margin | -5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sasmar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sasmar Pharmaceuticals Private Limited
Sasmar Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Andrew Jon Soutter | Director | 26 Jul 2019 | 7 Years 3 Months | Current |
| John Michael Mancini | Director | 05 Oct 2019 | 7 Years 1 Months | Current |
| Pankaj Srivastava Also directs: Xayad Projections Private Limited, XML (New Delhi) Private Limited, Bizbox Publishing Private Limited and 2 more | Director | 15 Oct 2021 | 5 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Sasmar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sasmar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sasmar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABCCS4161N1ZZ | Maharashtra | Active | 31 Dec 2021 |
To see the full GST registrations and return filing status of Sasmar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sasmar Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Ramasamy Sangilirajan ceased to be Director on 02 Feb 2022.
Frequently asked questions
Sasmar Pharmaceuticals is an active foreign private limited company based in Perungudi, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 July 2019 (7+ years old) and is registered under CIN U51909TN2019FTC130734.
Sasmar Pharmaceuticals has 3 current directors:
- Andrew Jon Soutter - Director
- John Michael Mancini - Director
- Pankaj Srivastava - Director
The latest financial statements of Sasmar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sasmar Pharmaceuticals is 27ABCCS4161N1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sasmar Pharmaceuticals is U51909TN2019FTC130734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sasmar Pharmaceuticals was incorporated on 26 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
Ramasamy Sangilirajan ceased to be Director on 02 Feb 2022. Pankaj Srivastava ceased to be Additional Director on 23 Nov 2021. Pankaj Srivastava was appointed as Director on 15 Oct 2021. Sasmar Pharmaceuticals has 5 board changes on record in total.
Sasmar Pharmaceuticals can be reached through the website sasmar.com. Its registered office is in Perungudi, Tamil Nadu, India.
The registered office of Sasmar Pharmaceuticals is at Disruptors Of Tomorrow Coworking No. 87 4th Cross Street 1st Main Road Thirumal, Ai Nagar, Perungudi, Tamil Nadu, India – 600096.
Sasmar Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
